Skip to main content
Clinical Trials/NCT01672320
NCT01672320
Withdrawn
N/A

Outcomes of Robotic Total Hip Arthroplasty: A Prospective Study

Massachusetts General Hospital1 site in 1 countryJanuary 2013
ConditionsOsteoarthritis

Overview

Phase
N/A
Intervention
Not specified
Conditions
Osteoarthritis
Sponsor
Massachusetts General Hospital
Locations
1
Primary Endpoint
Adverse Events
Status
Withdrawn
Last Updated
12 years ago

Overview

Brief Summary

The objectives of this study are to evaluate the clinical value of robotic-assisted total hip arthroplasty with respect to acetabular cup implantation, and to document the long-term clinical outcome of patients with Total Hip Arthroplasty (THA). IRB approval will be obtained at every study site to evaluate the basic clinical outcomes and post-operative component placement accuracy of each MAKO® THA patient.

The hypothesis is that robotic preparation of the acetabulum will significantly reduce the variability and inaccuracy in the component alignment parameters that lead to post-operative complications, including implant failure.

Registry
clinicaltrials.gov
Start Date
January 2013
End Date
January 2023
Last Updated
12 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Charles R. Bragdon

Research Scientist

Massachusetts General Hospital

Eligibility Criteria

Inclusion Criteria

  • Male or female
  • 20 to 75 years of age
  • Subjects requiring primary total hip replacement
  • Contralateral hip should be relatively free from arthritis for comparison purposes, specifically with less than a grade of 2 on the Kellgren-Lawrence Scale.
  • Subjects diagnosed with osteoarthritis or traumatic arthritis
  • Subjects with avascular necrosis
  • Subjects who demonstrate the ability to return for follow-up for the next 10 years

Exclusion Criteria

  • Subjects with difficulty understanding protocol for any reason
  • Subjects with a limited life span
  • Subjects with inflammatory hip disease, previous joint infection, or those requiring hip revision surgery
  • Female subjects who are pregnant, or who plan to get pregnant while enrolled in the study

Outcomes

Primary Outcomes

Adverse Events

Time Frame: 10 Years

Protocol deviations, complications, "lost to follow-up"

Survivorship of Components

Time Frame: 10 Years

Defined as implant remaining in subject.

Secondary Outcomes

  • Retrieval Analysis of implants from revision surgery(Up to 10 Years)

Study Sites (1)

Loading locations...

Similar Trials